MounjarovsWegovy
Both are GLP-1 receptor agonist • Side-by-side comparison
Mounjaro vs Wegovy: Overview
Mounjaro and Wegovy are both prescription medications used in clinical practice. Both Mounjaro and Wegovy belong to the GLP-1 receptor agonist drug class and work through similar mechanisms. Mounjaro is commonly used for Type 2 diabetes, Weight loss, while Wegovy is used for Weight loss. They differ in their active ingredients and may have different side effect profiles, dosing schedules, and drug interactions. As with all medications, your doctor will determine which is most appropriate based on your medical history, other medications, and specific health goals.
Key Facts at a Glance
- ✓Same drug class: GLP-1 receptor agonist
- ✓Mounjaro used for: Type 2 diabetes, Weight loss
- ✓Wegovy used for: Weight loss
- ✓Different active ingredients
- ✓Consult your doctor before switching between these medications
- ✓Individual response, tolerability, and cost affect the best choice
Mounjaro
Drug AUsed For
- ✓ Type 2 diabetes
- ✓ Weight loss
Wegovy
Drug BUsed For
- ✓ Weight loss
Key Differences
Which Should You Choose?
The best choice between Mounjaro and Wegovy depends on your specific diagnosis, medical history, other medications, and individual response to treatment. Since both are GLP-1 receptor agonist medications, your doctor may try one before the other based on your profile. Always work with your healthcare provider to find the medication that gives you the best results with the fewest side effects.